Delivery Order SPE2DB25D7056-SPE2DB25FTNEF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1.74K to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Atropine 8 mg/20 mL vials. The contract is a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive award. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply contract. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order valued at $1,269.70 to AmerisourceBergen Drug Corp for the supply of Atropine 0.4 mg/mL vials. This award, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, utilizes a firm fixed-price delivery order contract type with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,799.30 to AmerisourceBergen Drug Corp for Atropine 0.4 mg/mL vials, with an ultimate completion date of September 10, 2025. This competitively awarded, firm fixed-price contract involves no set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Atropine 0.4 mg/ml vials with a ceiling value of $1,375.09. This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order falls under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Atropine 1 mg/ml vials. This firm fixed-price delivery order, valued at $6,487.05, represents a non-competitive award with an ultimate completion date of August 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. The delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,083.52 to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/10 ml syringes on August 25, 2025, with completion scheduled for August 26, 2025. This firm fixed-price delivery order was awarded without set-aside designation and represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The...
- This delivery order, awarded on August 25, 2025, provides for the supply of Atropine 1 mg/ml vials to the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, with a ceiling value of $8,326.68 and a firm fixed price structure. The order is scheduled for completion by August 26, 2025, and represents a non-set-aside, competitively...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/10 mL syringes with a ceiling value of $1,393.00. The contract, which was competitively awarded without a set-aside designation, is classified as a firm fixed-price delivery order with an ultimate completion date of August 26, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Atropine 1 mg/mL vials with a ceiling value of $1,435.74. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 13, 2025. The award represents a delivery order against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical,...
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Atropine 1 mg/mL vials with a ceiling value of $3,895.01. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The order is scheduled for completion by August 26, 2025, and represents a routine procurement of critical pharmaceutical...
- SPE2DB25D7056Indefinite Delivery Contract
- SPE2DB25D7056-SPE2DB25FTNEFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,362.26 to AmerisourceBergen Drug Corp for the supply of Atropine 8 mg/20 mL vials on September 9, 2025, with completion expected by September 10, 2025. This firm fixed-price delivery order was awarded competitively without set-aside designations and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen Drug Corp's broader relationship with the Defense Logistics Agency. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen Drug Corp serves critical federal medical procurement needs for military and veteran healthcare systems, with an extensive portfolio demonstrating capability to meet competitive federal procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 9/9/25 |